A Study of DC6001 Tablet in Healthy Chinese Adult Subjects

Clinical trial NCT07417566 · RECRUITING

Trial details

NCT number: NCT07417566
Sponsor: Heronova Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Stargardt Disease

Start date: 2026-01-01
Primary completion: 2026-12-31
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.